Halozyme Therapeutics (HALO) Times Interest Earned (2011 - 2026)
Halozyme Therapeutics' (HALO) quarterly Times Interest Earned came in at $33.5 in Q1 2026, up 7.1% year-on-year from $31.28 in Q1 2025, and up 202.07% on a QoQ basis from $11.09 in Q4 2025.
Halozyme Therapeutics (HALO) Times Interest Earned (2011 - 2026) Analysis & Trends
Halozyme Therapeutics (HALO) has 15 years of Times Interest Earned data on file, last reported at $33.5 in Q1 2026.
- On a quarterly basis, Times Interest Earned rose 7.1% year-over-year to $33.5 in Q1 2026; TTM through Mar 2026 was $84.61, a 156.51% increase from a year earlier, with the FY2025 full-year figure at $25.87, down 15.1% from the prior year.
- Times Interest Earned for Q1 2026 stood at $33.5, up from $11.09 in the prior quarter.
- Over the last five years, Times Interest Earned for HALO reached as high as $46.07 in Q2 2025 and fell as low as $6.0 in Q3 2025.
- Historically, Times Interest Earned has averaged $24.17 across 5 years, with a median of $21.2 in 2024.
- Across the five-year window, Times Interest Earned jumped 91.55% in 2023 and sank 83.36% in 2025, its largest moves.
- Year by year, Times Interest Earned stood at $16.3 in 2022, then soared by 67.08% to $27.24 in 2023, then jumped by 41.91% to $38.66 in 2024, then plunged by 71.31% to $11.09 in 2025, then jumped by 202.07% to $33.5 in 2026.
- Per Business Quant data, the three most recent Times Interest Earned figures were $33.5 in Q1 2026, $11.09 in Q4 2025, and $6.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Halozyme Therapeutics | 9.55 Bn | 9.23 Bn | 297.47 Mn | 33.50 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.50 |
| Dec 31, 2025 | 11.09 |
| Sep 30, 2025 | 6.00 |
| Jun 30, 2025 | 46.07 |
| Mar 31, 2025 | 31.28 |
| Dec 31, 2024 | 38.66 |
| Sep 30, 2024 | 36.07 |
| Jun 30, 2024 | 25.91 |
| Mar 31, 2024 | 21.20 |
| Dec 31, 2023 | 27.24 |
| Sep 30, 2023 | 19.60 |
| Jun 30, 2023 | 21.02 |
| Mar 31, 2023 | 11.84 |
| Dec 31, 2022 | 16.30 |
| Sep 30, 2022 | 11.08 |
| Jun 30, 2022 | 10.97 |
| Mar 31, 2022 | 43.02 |
| Dec 31, 2021 | 27.51 |
| Sep 30, 2021 | 43.09 |
| Jun 30, 2021 | 53.11 |